2-(3-ôÈ»ù-1-±ûõ£°±»ù)-2-ÍÑÑõ-D-ÆÏÌÑÌÇ,2-(3-carboxy-1-oxopropyl)amino-2-deoxy-D-GlucoseÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ²Ï¶¹¸ù¼â΢ºË¼¼Êõ,VAMCNÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« θʳ¹ÜÎǺÏÊõ,GastroesophagectomyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÂÌŧ¸Ë¾úÖÆ¼Á,PA-MSHAÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ºÚÉ«ËØÁö/Íâ¿ÆÑ§,melanoma/SUÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ²¡ËÀ,fatalityÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« °¬Á¦,CPT-¢òÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ±íÃæÔöÇ¿¼¤¹â½âÎüµçÀë-·ÉÐÐʱ¼äÖÊÆ×,SELDI-TOF-MSÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÒÁÀûÌæ¿µ,IrinotecanÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÁܰÍÁö/²¢·¢Ö¢,Lymphoma/COÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« 5-LOX,5-lipoxygeaseÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Ö×Áö·¢Éú·¢Õ¹,tamorigenesisÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¼×»ùÁò´úÏÙÜÕ,methylthioadenosineÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« RKOϸ°û,RKOÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ËÀÍöÊÜÌå4,DcR1Ó¢Óï¶Ì¾ä,Àý¾ä´óÈ« Ö×Áö½µÆÚ,Down-stagingÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« mp53,VEGFÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ·ÇѪÐÔ,Non-bloodyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¸ÆÕ³µ°°×»ùÒò,E-cadherinÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Áò»ù×ªÒÆÃ¸Àà,SulfurtransferasesÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Àû¿¨Í¡,LicartinÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÒÁÁ¢Ì濵(CPT-11),Irinotecan(CPT-11)Ó¢Óï¶Ì¾ä,Àý¾ä´óÈ« ·úÄòà×à¤/ÑÇÒ¶Ëá¸Æ,fluorouracilÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ½á³¦ÇгýÊõ/·½·¨,Colectomy/methodsÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Ѫ½¬TÁܰÍϸ°ûAgNORs,Tc-AgÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Ñ»µ¨×ÓÈé¼Á,YaDanZiRuJiÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« µ¥²ãÎǺÏÊõ,AnastomosisÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ·ÅÉäѧ/½éÈëÐÔ,Radiology/InterventionÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« P16/ÃâÒßѧ,P16/immunologyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« herg1»ùÒò,herg1Ó¢Óï¶Ì¾ä,Àý¾ä´óÈ« Ѫ¹Ü¼¡Ö¬Áö/²¡Àíѧ,angionyolipoma/pathologyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« I-¦ÊB¦Á,¢ñ-¦ÊB¦ÁÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÄÉÃ×ÄÒÅÝ,niosomesÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« PD 98059,PD98059Ó¢Óï¶Ì¾ä,Àý¾ä´óÈ« ½á¹¹Ö¬·¾Èé¼Á,StructolipidÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¿¹Ô­CD117,CD117Ó¢Óï¶Ì¾ä,Àý¾ä´óÈ« ѪÇåÉúÀíѧ,serophysiologyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÄÚÀ¨Ô¼¼¡ÇгýÊõ,BiofeedbackÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Á×Ö¬õ£ÒÒ´¼°·-N-¼×»ù×ªÒÆÃ¸2,Phosphatidylethanolamine-N-methyltransferase-2Ó¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÈËÊÈËáÐÔϸ°ûÉñ¾­¶¾ËØ,hEDNÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ºÉ°üǯ,SSTÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ΢´´Ê³¹ÜÇгýÊõ,esophagectomyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÍØÆËÒ칹ø-1,Topoisomerase-1Ó¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¸Î¶¯ÂöÔìÓ°CT,SD-CTHAÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ϸ°û½ÇÖʵ°°×19Ƭ¶Î,CYFRA211Ó¢Óï¶Ì¾ä,Àý¾ä´óÈ« ʳ¹ÜθÎǺϿÚÏÁÕ­,dilatationÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÔÙÊÖÊõÇгý,re-resectionÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ephrin B2,ephrinB2Ó¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÁܰÍÁö/Íâ¿ÆÑ§,lymphoma/SUÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« µ¨µÀ°©Ë¨,TTBDÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ×ÔÉíÃâÒß¿¹Ìå,self-antibodyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÈÈÐÝ¿Ëת¼Òò×Ó1,hHSF1Ó¢Óï¶Ì¾ä,Àý¾ä´óÈ« Òº»ù±¡Æ¬,ThinprepÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Õ³Òº/Õï¶Ï,mucinous/diagnosisÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« µ¨¹Ì´¼/²¡Òòѧ,cholesterol/etiolÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¸Î¶¯Âöµ¼¹Ü»¯ÁÆË¨Èû,HAEÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« DCC»ùÒò,DCCÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« θ¹¦ÄÜÐÔÅÅ¿ÕÕϰ­,GastroplegiaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÈÈ»¯ÁÆË¨Èû,ThermochemoembolotherapyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ˨Èû/ÖÎÁÆÐÔ,Embolization/therapeuticÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÒÒ×´½á³¦¾µ,SigmoidoscopeÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÊõºóÉú´æ,prognosisÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ³É½ºÖÊϸ°ûÁö,GlioblastomaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« HNF6,HNF?6Ó¢Óï¶Ì¾ä,Àý¾ä´óÈ« ·´Òå¹ÑºËÜÕËá¼¼Êõ,As-ODNÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« p21WAF,p21~(WAF)Ó¢Óï¶Ì¾ä,Àý¾ä´óÈ« ϸ°ûÍâÐźŵ÷½Ú¼¤Ã¸5,ERK5Ó¢Óï¶Ì¾ä,Àý¾ä´óÈ« Õï¶ÏÔ¤²â,judgement-predictionÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« GLQIÖ¸Êý,GLQIÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ´¨±±µØÇø,North-SichuanÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ƽ»¬¼¡ÈâÁö/Õï¶Ï,leiomyosarcoma/diagonosisÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« È˽᳦°©Ï¸°ûCaco-2,Caco-2Ó¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÍÃÁÛ°©Ï¸°ûÖê,VX2Ó¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÈËθ°©SGC-7901ϸ°û,SGC-7901Ó¢Óï¶Ì¾ä,Àý¾ä´óÈ« °©Åß¿¹Ô­µ°°×,CEApÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÀÒË¿çÓëÄ(YSV),YSVÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ²Ð°©,MetastasisÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ½µÆÚ,downstageÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Ôª±¦·ã»ÆÍª,FlavoneÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÒÈÏÙµ¼¹ÜÄÚÈéÍ·×´Õ³ÒºÐÔÖ×Áö,IPMNÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Rho/ROCK,HBMECÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ×éµ°°×ÍÑÒÒõ£»¯Ã¸ÒÖÖÆ¼Á,5-aza-cytidineÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÊõÖл¯ÁÆ,chemotheraÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« HtrA2/Omi,ParkinÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ΢СRNA-122,miR-122Ó¢Óï¶Ì¾ä,Àý¾ä´óÈ« ½á³¦ÏµÄ¤,mesocolonÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ½áµÞ×éÖ¯Áö,mesocytomaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÔöÖ³/µòÍö,proliferation/apoptosisÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« µØÓòÏà¹ØÐÔ,region-restrictedÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Éñ¾­ºËµ°°×¦Ã,¦Ã-synÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« N-¾ÛÌÇ,N-glycanÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÑǸζÎ,SubsegmentalÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« S-1,5-·úÄòà×à¤,s-1,5-FuÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« p16,5-µªÔÓ-2'-ÍÑÑõ°ûÜÕ(5-Aza-CdR),p16,5-aza-2'-deoxycytidineÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« °ÂɳÀû²¬/»¯ÁÆ,oxaliplatin/chemotherapyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« CDK2µ°°×,CDK2Ó¢Óï¶Ì¾ä,Àý¾ä´óÈ« BRAFµ°°×,BRAFÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¶ËÁ£Ã¸Äæ×ªÂÌøÆô¶¯×Ó,mTERT-promoterÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¢ñÐÍPI3K,Class¢ñPI3KÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¢óÐÍPI3K,Class¢óPI3KÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«